All lobbying filings

LEAVITT PARTNERS, LLC

LEAVITT PARTNERS, LLC filed a Q1 report for SICKLE CELL DISEASE PARTNERSHIP on April 20, 2026, reporting $20,000 in lobbying income.

Lobbying for SICKLE CELL DISEASE PARTNERSHIP · Alliance of patient advocates, plans, providers & manufacturers focused on federal policy.

All filings by LEAVITT PARTNERS, LLC · Everything SICKLE CELL DISEASE PARTNERSHIP has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 2

JOSH TRENT

Previously held: Chief Health Counsel for Chairman - House E&C Committee (E&C); Deputy Chief Health Counsel - E&C; Professional Staff - E&C; Health Care Policy Advisor - Senate; Deputy Director Office of Refugee Resettlement HHS; WH Office of Presidential Personnel
ROBERT CLAYTON ALSPACH

Previously held: Chief Health Counsel for Chairman - House E&C Committee (E&C);Counsel - E&C, Clerk - E&C, and Paid Intern - E&C

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Sickle cell disease focused legislation, federal funding, and federal programs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.